These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28766204)

  • 1. Nonoperative Management for Invasive Breast Cancer After Neoadjuvant Systemic Therapy: Conceptual Basis and Fundamental International Feasibility Clinical Trials.
    Kuerer HM; Vrancken Peeters MTFD; Rea DW; Basik M; De Los Santos J; Heil J
    Ann Surg Oncol; 2017 Oct; 24(10):2855-2862. PubMed ID: 28766204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying pathologic complete response of the breast after neoadjuvant systemic therapy with ultrasound guided biopsy to eventually omit surgery: Study design and feasibility of the MICRA trial (Minimally Invasive Complete Response Assessment).
    van der Noordaa MEM; van Duijnhoven FH; Loo CE; van Werkhoven E; van de Vijver KK; Wiersma T; Winter-Warnars HAO; Sonke GS; Vrancken Peeters MTFD
    Breast; 2018 Aug; 40():76-81. PubMed ID: 29698928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Clinical Feasibility Trial for Identification of Exceptional Responders in Whom Breast Cancer Surgery Can Be Eliminated Following Neoadjuvant Systemic Therapy.
    Kuerer HM; Rauch GM; Krishnamurthy S; Adrada BE; Caudle AS; DeSnyder SM; Black DM; Santiago L; Hobbs BP; Lucci A; Gilcrease M; Hwang RF; Candelaria RP; Chavez-MacGregor M; Smith BD; Arribas E; Moseley T; Teshome M; Miggins MV; Valero V; Hunt KK; Yang WT
    Ann Surg; 2018 May; 267(5):946-951. PubMed ID: 28549010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Patients With Documented Pathologic Complete Response in the Breast After Neoadjuvant Chemotherapy for Omission of Axillary Surgery.
    Tadros AB; Yang WT; Krishnamurthy S; Rauch GM; Smith BD; Valero V; Black DM; Lucci A; Caudle AS; DeSnyder SM; Teshome M; Barcenas CH; Miggins M; Adrada BE; Moseley T; Hwang RF; Hunt KK; Kuerer HM
    JAMA Surg; 2017 Jul; 152(7):665-670. PubMed ID: 28423171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omission of Breast Surgery in Predicted Pathologic Complete Response after Neoadjuvant Systemic Therapy: A Multicenter, Single-Arm, Non-inferiority Trial.
    Jung JJ; Cheun JH; Kim SY; Koh J; Ryu JM; Yoo TK; Shin HC; Ahn SG; Park S; Lim W; Nam SE; Park MH; Kim KS; Kang T; Lee J; Youn HJ; Kim YS; Yoon CI; Kim HK; Moon HG; Han W; Cho N; Kim MK; Lee HB
    J Breast Cancer; 2024 Feb; 27(1):61-71. PubMed ID: 38433091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosing Pathologic Complete Response in the Breast After Neoadjuvant Systemic Treatment of Breast Cancer Patients by Minimal Invasive Biopsy: Oral Presentation at the San Antonio Breast Cancer Symposium on Friday, December 13, 2019, Program Number GS5-03.
    Heil J; Pfob A; Sinn HP; Rauch G; Bach P; Thomas B; Schaefgen B; Kuemmel S; Reimer T; Hahn M; Thill M; Blohmer JU; Hackmann J; Malter W; Bekes I; Friedrichs K; Wojcinski S; Joos S; Paepke S; Ditsch N; Rody A; Große R; van Mackelenbergh M; Reinisch M; Karsten M; Golatta M;
    Ann Surg; 2022 Mar; 275(3):576-581. PubMed ID: 32657944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omission of Breast Surgery in Exceptional Responders.
    Tasoulis MK; Lee HB; Kuerer HM
    Clin Breast Cancer; 2024 Jun; 24(4):310-318. PubMed ID: 38365541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of multi-parametric breast MR imaging for predicting pathological complete response of operable breast cancer prior to neoadjuvant systemic therapy.
    Tsukada H; Tsukada J; Schrading S; Strobel K; Okamoto T; Kuhl CK
    Magn Reson Imaging; 2019 Oct; 62():242-248. PubMed ID: 31352016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vacuum-Assisted Breast Biopsy After Neoadjuvant Systemic Treatment for Reliable Exclusion of Residual Cancer in Breast Cancer Patients.
    Koelbel V; Pfob A; Schaefgen B; Sinn P; Feisst M; Golatta M; Gomez C; Stieber A; Bach P; Rauch G; Heil J
    Ann Surg Oncol; 2022 Feb; 29(2):1076-1084. PubMed ID: 34581923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RESPONDER - diagnosis of pathological complete response by vacuum-assisted biopsy after neoadjuvant chemotherapy in breast Cancer - a multicenter, confirmative, one-armed, intra-individually-controlled, open, diagnostic trial.
    Heil J; Sinn P; Richter H; Pfob A; Schaefgen B; Hennigs A; Riedel F; Thomas B; Thill M; Hahn M; Blohmer JU; Kuemmel S; Karsten MM; Reinisch M; Hackmann J; Reimer T; Rauch G; Golatta M
    BMC Cancer; 2018 Aug; 18(1):851. PubMed ID: 30144818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing Accuracy of Mammography and Magnetic Resonance Imaging for Residual Calcified Lesions in Breast Cancer Patients Undergoing Neoadjuvant Systemic Therapy.
    Um E; Kang JW; Lee S; Kim HJ; Yoon TI; Sohn G; Chung IY; Kim J; Lee JW; Son BH; Ahn SH; Ko BS
    Clin Breast Cancer; 2018 Oct; 18(5):e1087-e1091. PubMed ID: 29703689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant Therapy for HER2-positive Breast Cancer.
    Wuerstlein R; Harbeck N
    Rev Recent Clin Trials; 2017; 12(2):81-92. PubMed ID: 28164759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiparametric MR imaging to assess response following neoadjuvant systemic treatment in various breast cancer subtypes: Comparison between different definitions of pathologic complete response.
    Santamaría G; Bargalló X; Ganau S; Alonso I; Muñoz M; Mollà M; Fernández PL; Prat A
    Eur J Radiol; 2019 Aug; 117():132-139. PubMed ID: 31307638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance and Practice Guideline for the Use of Neoadjuvant Systemic Therapy in the Management of Breast Cancer.
    Holmes D; Colfry A; Czerniecki B; Dickson-Witmer D; Francisco Espinel C; Feldman E; Gallagher K; Greenup R; Herrmann V; Kuerer H; Malik M; Manahan E; O'Neill J; Patel M; Sebastian M; Wheeler A; Kass R
    Ann Surg Oncol; 2015 Oct; 22(10):3184-90. PubMed ID: 26224406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraoperative Ultrasound-Guided Excision of Axillary Clip in Patients with Node-Positive Breast Cancer Treated with Neoadjuvant Therapy (ILINA Trial) : A New Tool to Guide the Excision of the Clipped Node After Neoadjuvant Treatment.
    Siso C; de Torres J; Esgueva-Colmenarejo A; Espinosa-Bravo M; Rus N; Cordoba O; Rodriguez R; Peg V; Rubio IT
    Ann Surg Oncol; 2018 Mar; 25(3):784-791. PubMed ID: 29197044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multidisciplinary team and patient perspective on omission of surgery after neoadjuvant systemic therapy for early breast cancer: A European Society of Surgical Oncology (ESSO) Research Academy survey.
    Caballero C; Lundon DJ; Vasileva-Slaveva M; Montagna G; Bonci EA; Brandl A; Smith H; Kok JHH; Holmberg CJ; Sayyed R; Santrac N; Suppan I; Kaul P; Vassos N; Lorenzon L; Murphy M; Ceelen W; de Azambuja E; McIntosh SA; Rubio IT
    Eur J Surg Oncol; 2024 Oct; 50(10):108585. PubMed ID: 39146663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective elimination of breast cancer surgery in exceptional responders: historical perspective and current trials.
    van la Parra RF; Kuerer HM
    Breast Cancer Res; 2016 Mar; 18(1):28. PubMed ID: 26951131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality assessment of neoadjuvant therapy use in breast conservation: barriers to implementation.
    James T; McCahill L; Ratliff J; Ashikaga T; Single R; Sheehey-Jones J; Messier N; Stanley M; Krag D; Harlow S
    Breast J; 2009; 15(5):524-6. PubMed ID: 19624412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommendations from an international consensus conference on the current status and future of neoadjuvant systemic therapy in primary breast cancer.
    Kaufmann M; von Minckwitz G; Mamounas EP; Cameron D; Carey LA; Cristofanilli M; Denkert C; Eiermann W; Gnant M; Harris JR; Karn T; Liedtke C; Mauri D; Rouzier R; Ruckhaeberle E; Semiglazov V; Symmans WF; Tutt A; Pusztai L
    Ann Surg Oncol; 2012 May; 19(5):1508-16. PubMed ID: 22193884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-Enhanced Spectral Mammography is Comparable to MRI in the Assessment of Residual Breast Cancer Following Neoadjuvant Systemic Therapy.
    Patel BK; Hilal T; Covington M; Zhang N; Kosiorek HE; Lobbes M; Northfelt DW; Pockaj BA
    Ann Surg Oncol; 2018 May; 25(5):1350-1356. PubMed ID: 29516362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.